Annovis Bio, Inc. Shares Issued
Annovis Bio, Inc. (ANVS) had Shares Issued of 42.61 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-14
- 2026-06-30: Common Stock, Shares, Issued 42.61M shares.
- 2026-03-31: Common Stock, Shares, Issued 28.54M shares.
- 2025-12-31: Common Stock, Shares, Issued 27.20M shares.
- 2025-09-30: Common Stock, Shares, Issued 20.19M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 42.61M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 28.54M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 27.20M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 20.19M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 19.49M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 19.49M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 14.14M shares 10-K · filed 2026-03-13 |
| 2024-09-30 | 13.28M shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 11.72M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 11.01M shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 10.52M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 9.01M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 9.01M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 8.22M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 8.16M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 8.16M shares 10-Q · filed 2023-11-08 |
| 2022-06-30 | 8.16M shares 10-Q · filed 2023-08-14 |
| 2022-03-31 | 8.16M shares 10-Q · filed 2023-05-10 |
| 2021-12-31 | 8.10M shares 10-Q · filed 2023-11-08 |
| 2021-09-30 | 8.10M shares 10-Q · filed 2021-11-03 |
| 2021-06-30 | 8.09M shares 10-Q · filed 2021-07-28 |
| 2021-03-31 | 6.95M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 6.89M shares 10-K · filed 2022-03-02 |
| 2020-09-30 | 6.87M shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 6.87M shares 10-Q · filed 2020-07-29 |
| 2020-03-31 | 6.85M shares 10-Q · filed 2020-05-05 |
| 2019-12-31 | 282.61K shares 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |